Jean-Simon Diallo Selected Research

Antigens

1/2024	Immune profiling of dedifferentiated liposarcoma and identification of novel antigens for targeted immunotherapy.
12/2023	A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.
12/2020	Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.
4/2013	HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Simon Diallo Research Topics

Disease

56	Neoplasms (Cancer) 05/2024 - 05/2006
13	Infections 11/2023 - 12/2010
9	Prostatic Neoplasms (Prostate Cancer) 01/2011 - 05/2006
6	COVID-19 12/2023 - 01/2021
5	Virus Diseases (Viral Diseases) 11/2023 - 06/2010
5	Vesicular Stomatitis 01/2023 - 12/2010
4	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2016
4	Melanoma (Melanoma, Malignant) 01/2023 - 03/2021
3	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2009
2	Brain Neoplasms (Brain Tumor) 05/2024 - 02/2013
2	Inflammation (Inflammations) 01/2024 - 05/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2018
2	Multiple Sclerosis 01/2023 - 01/2018
2	Leukemia 01/2021 - 07/2013
2	Vaccinia 08/2015 - 12/2010
2	Prostatic Intraepithelial Neoplasia 12/2007 - 05/2006
2	Margins of Excision 12/2007 - 08/2007
1	Liposarcoma 01/2024
1	Herpes Simplex 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Bites and Stings (Sting) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Malaria 11/2021
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Triple Negative Breast Neoplasms 01/2018

Drug/Important Bio-Agent (IBA)

19	Antiviral Agents (Antivirals)IBA 05/2024 - 09/2008
11	VaccinesIBA 12/2023 - 09/2012
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2024 - 09/2012
5	Proteins (Proteins, Gene)FDA Link 12/2023 - 05/2010
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 10/2011
5	InterferonsIBA 03/2021 - 12/2010
5	Hormones (Hormone)IBA 05/2009 - 05/2006
4	AntigensIBA 01/2024 - 04/2013
4	CytokinesIBA 01/2016 - 05/2009
4	AndrogensIBA 05/2008 - 09/2006
3	VanadiumIBA 01/2022 - 01/2018
3	Histone Deacetylase InhibitorsIBA 04/2013 - 09/2008
3	ErbB Receptors (EGF Receptor)IBA 04/2012 - 05/2006
3	Androgen Receptors (Androgen Receptor)IBA 05/2008 - 09/2006
2	Peptides (Polypeptides)IBA 05/2023 - 08/2011
2	Interleukin-12 (IL 12)IBA 05/2023 - 01/2022
2	Dimethyl FumarateIBA 01/2023 - 01/2018
2	maleic acid (maleate)IBA 01/2023 - 01/2018
2	EstersIBA 01/2023 - 01/2018
2	Vanadates (Orthovanadate)IBA 01/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2009
2	Interferon Type IIBA 03/2021 - 04/2012
2	Firefly LuciferasesIBA 09/2014 - 06/2011
2	Phytic Acid (Inositol Hexaphosphate)IBA 01/2011 - 09/2006
2	I-kappa B KinaseIBA 05/2009 - 01/2007
2	NF-kappa B (NF-kB)IBA 05/2007 - 01/2007
1	4-octyl itaconateIBA 05/2024
1	itaconic acidIBA 05/2024
1	Cysteine (L-Cysteine)FDA Link 05/2024
1	COVID-19 VaccinesIBA 12/2023
1	EpitopesIBA 12/2023
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 11/2023
1	pevonedistatIBA 11/2023
1	ChlorotoxinIBA 05/2023
1	Ado-Trastuzumab EmtansineIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	Colistin (Coly-Mycin)FDA Link 06/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	bifonazoleIBA 01/2022
1	cyclic diadenosine phosphateIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	proguanil drug combination atovaquone (malarone)FDA Link 11/2021
1	Atovaquone (Mepron)FDA Link 11/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2021
1	vanadyl sulfateIBA 03/2021
1	Protein Tyrosine PhosphatasesIBA 03/2021
1	AntibodiesIBA 12/2020
1	OvalbuminIBA 12/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	SaltsIBA 01/2019
1	CationsIBA 01/2019
1	LigandsIBA 01/2019
1	Drug CombinationsIBA 10/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Vanadium CompoundsIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	MTOR InhibitorsIBA 01/2018
1	Eukaryotic Initiation Factor-4EIBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Cancer VaccinesIBA 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2018

Therapy/Procedure

21	Therapeutics 11/2023 - 01/2007
15	Immunotherapy 01/2024 - 04/2013
12	Oncolytic Virotherapy 05/2024 - 02/2010
3	Prostatectomy (Retropubic Prostatectomy) 05/2008 - 05/2006
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
1	RNAi Therapeutics 11/2023
1	Intranasal Administration 01/2022
1	Chemoprevention 11/2021
1	Radiotherapy 01/2021